Compared with the preonset of NAFLD, metabolism-related indicators such as BMI, WC, triglyceride, HDL, apolipoprotein-A1 (Apo-A1), and fasting blood glucose (FBG) increased, and LDL and apolipoprotein-B (Apo-B) decreased. The gene discussed is APOA1; the disease is metabolic dysfunction-associated steatotic liver disease.